Naoshi Obara

Tsukuba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 105 publications

HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in patients with myelofibrosis

HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in patients with myelofibrosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in Japan.

Long-term safety and effectiveness of romiplostim in patients with refractory aplastic anemia: a nationwide, all-case, post-marketing surveillance study in Japan.

Journal: Annals of hematology

Published: March 25, 2026

Eltrombopag-induced clinically negligible negative bias in creatinine measurements using enzymatic assays.

Eltrombopag-induced clinically negligible negative bias in creatinine measurements using enzymatic assays.

Journal: Clinical chemistry and laboratory medicine

Published: February 09, 2026

Overview

Overview

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 12, 2026

Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study.

Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study.

Journal: Cureus

Published: December 28, 2025

Concentration dependency of an acyl glucuronide metabolite in eltrombopag-induced hepatotoxicity: Role of UGT1A1 genotype.

Concentration dependency of an acyl glucuronide metabolite in eltrombopag-induced hepatotoxicity: Role of UGT1A1 genotype.

Journal: British journal of clinical pharmacology

Published: December 24, 2025

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

Journal: British journal of haematology

Published: December 05, 2025

Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world survey.

Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world survey.

Journal: International journal of hematology

Published: November 12, 2025

Tumor necrosis factor from leukemic environment stimulates hematopoietic stem/progenitor cells toward megakaryocyte/myeloid lineage bias.

Tumor necrosis factor from leukemic environment stimulates hematopoietic stem/progenitor cells toward megakaryocyte/myeloid lineage bias.

Journal: Experimental hematology

Published: November 08, 2025

Tracking of Donor Erythropoiesis following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.

Tracking of Donor Erythropoiesis following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: October 27, 2025

Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Journal: Hematological oncology

Published: June 26, 2025

Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack.

Case report: Spontaneous remission of severe aplastic anemia mediated by mutant hematopoietic stem cells evading T-cell attack.

Journal: Frontiers in immunology

Published: May 27, 2025

Showing 1-12 of 105

Last Updated: 09/26/2026